Standard Biotools Inc. (LAB): Shares Outstanding

Annual figures by period end, from SEC filings.

386.38M
As of 2025-12-31
392.12M
As of 2026-06-30
+69.4%
3-year compound annual growth
+39.0%
5-year compound annual growth
+29.6%
10-year compound annual growth
2010-12-31: 1.94M2011-12-31: 20.32M2012-12-31: 25.11M2013-12-31: 25.81M2014-12-31: 28.34M2015-12-31: 28.84M2016-12-31: 29.21M2017-12-31: 38.79M2018-12-31: 49.34M2019-12-31: 69.96M2020-12-31: 74.54M2021-12-31: 76.92M2022-12-31: 79.48M2023-12-31: 80.23M2024-12-31: 377.53M2025-12-31: 386.38M386.38M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31386.38M+2.3%2026-03-16, Balance as of period end
2024-12-31377.53M+370.5%2026-03-16, Balance as of period end
2023-12-3180.23M+0.9%2025-03-11, Balance as of period end
2022-12-3179.48M+3.3%2024-03-01, Balance as of period end
2021-12-3176.92M+3.2%2023-03-14, Balance as of period end
2020-12-3174.54M+6.6%2022-03-08, Balance as of period end
2019-12-3169.96M+41.8%2021-02-25, Balance as of period end
2018-12-3149.34M+27.2%2020-02-27, Balance as of period end
2017-12-3138.79M+32.8%2019-03-18, Balance as of period end
2016-12-3129.21M+1.3%2018-03-08, Balance as of period end
2015-12-3128.84M+1.8%2017-03-03, Balance as of period end
2014-12-3128.34M+9.8%2016-02-29, Balance as of period end
2013-12-3125.81M+2.8%2015-02-26, Balance as of period end
2012-12-3125.11M+23.6%2014-03-12, Balance as of period end
2011-12-3120.32Mn/c2013-03-12, Balance as of period end
2010-12-311.94Mn/a2012-03-26, Balance as of period end